<DOC>
	<DOCNO>NCT01902303</DOCNO>
	<brief_summary>The purpose study determine new drug treatment effective block development cold sore lesion follow Ultra Violet ( UV ) exposure .</brief_summary>
	<brief_title>Evaluation Cold Sore Treatments Ultra Violet ( UV ) Induced Cold Sores</brief_title>
	<detailed_description>This multi-center , randomize , evaluator subject-blind , placebo control study design The objective study evaluate ability test article block development cold sore lesion progress beyond prodromal stage follow UV-induced process . The primary efficacy endpoint study determine recurrent oral herpes episode initiate prodromal symptom abort progress lesion ( vesicle ) via assess lesion stage train evaluator . The secondary efficacy endpoint include : ) subject self-assessments b ) test article weight diaries track treatment compliance .</detailed_description>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Herpes Labialis</mesh_term>
	<mesh_term>Stomatitis , Herpetic</mesh_term>
	<criteria>Clinical history recurrent cold sores average 2 episode per year UV exposure know cause cold sore outbreak History abnormal reaction sunlight Used antiviral therapy directly prior enter study Any condition opinion Investigator may affect result place subject undue risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Herpes Labialis</keyword>
	<keyword>Herpes Simplex</keyword>
	<keyword>Herpes</keyword>
	<keyword>Ultra Violet ( UV ) Induced</keyword>
</DOC>